Skip Navigation

European Heart Journal 1993 14(8):1040-1043;
Copyright © 1993 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by KONTNY, F.
Right arrow Articles by MORSTØL, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KONTNY, F.
Right arrow Articles by MORSTØL, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 The Europen Society of Cardiology

Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin

F. KONTNY*,, J. DALE*, U. ABILDGAARD*, L. HEGRENAES{dagger}, P. LEM{ddagger} and T. MORSTØL§

*Medical Department, Aker University Hospital Oslo, Norway
{dagger}Medical Department, Regionssykehuset i Trondheim Norway
{ddagger}Medical Department, Moss County Hospital Norway
§Medical Department, Central Hospital in Møre and Romsdal Ålesund, Norway

Received 23 November 1992; revised 26 February 1993; .

Correspondence Frederic Kontny, MD. Medical Department, Aker University Hospital, N-0514 Oslo, Norway

Abstract

In a prospective non-randomized study, 229 patients with a verfied first acute anterior myocardial infarction (AAMI) underwent echocardiography before discharge in order to study left ventricular (LV) thrombus formation. Antithrombotic therapy was given according to the routine of each centre.

Patients receiving high-dose heparin had few LV thrombi, irrespective of warfarin therapy (6/32 vs 3/25, P ns). In patients not given heparin, however, a significantly higher prevalence of LV thrombi was found in a subgroup of patients treated with warfarin as compared to those who did not receive warfarin (8/13 vs 17/68, P 0.02). A similar, but non-significant difference was observed in patients given low-dose heparin (42% vs 27%, P ns). Within the non-heparin and low-dose heparin groups, age, infarct size, occurrence of Q-wave infarction, congestive heart failure and LV wall motion impairment did not differ between those treated or not treated with warfarin.

In conclusion, high-dose heparin seems effective in the prevention of LV thrombosis irrespective of warfarin therapy after AAMI. The start of warfarin therapy in patients not receiving heparin was, however, associated with an increased prevalence of LV thrombosis.

Key Words: Acute myocardial infarction • left ventricular thrombosis • oral anticoagulation • adverse effects


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
H. S. Friedman, L. Chelluri, C. A. Sirio, D. C. Angus, K. Ogunyankin, E. J. Topol, R. M. Califf, F. Van de Werf, and V. Fuster
Thrombolytic Therapy for Acute Myocardial Infarction: GUSTO Criticized
N. Engl. J. Med., February 17, 1994; 330(7): 504 - 506.
[Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.